Filing Flows › ClearPoint Neuro (CLPT) › Q3 2025
ClearPoint Neuro (CLPT) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 6, 2025
ClearPoint Neuro (CLPT) reported revenue of $8.9M for the third quarter 2025 (Q3 2025), +9% from a year earlier and -4% from the quarter before. Operating margin was -59.5%, net loss $5.9M (66.5% of revenue).
ClearPoint Neuro, Q3 2025: revenue $8.9M (+9% year over year), operating margin -59.5%, net loss $5.9M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.9M | -4% | +9% |
| Operating profit | −$5.3M | — | — |
| Net earnings | −$5.9M | — | — |
| Operating cash flow | −$3.1M | — | — |
What changed
Revenue was $8.9M in Q3 2025, up 9% year over year and down 4% from the previous quarter. Service was the largest line at 39% of revenue. Service added $852K year over year (up 32%), 115% of the total change.
Gross margin was 63.2%, up 3.5 points from a year earlier. Operating costs exceeded revenue by $5.3M, an operating margin of -59.5%. Operating expenses grew 9% against revenue growth of 9%. The fastest-growing cost line was SG&A (+14%). The quarter ended with a net loss of $5.9M, wider than the previous quarter's $5.8M loss.
Operating cash flow was −$3.1M. Non-cash charges added back $66K of depreciation and amortization and $2.0M of share-based compensation. Working capital and other items added $682K. Capital expenditures of $199K exceeded it, leaving free cash flow of −$3.3M.
Questions
What was ClearPoint Neuro's revenue in the third quarter 2025?
ClearPoint Neuro (CLPT) reported revenue of $8.9M for the third quarter 2025 (Q3 2025), +9% from a year earlier and -4% from the quarter before.
Was ClearPoint Neuro profitable in the third quarter 2025?
Operating loss was $5.3M (-59.5% of revenue) and net loss $5.9M.
Source: ClearPoint Neuro 10-Q on SEC EDGAR.